Pierre Amarenco Selected Research

Transient Ischemic Attack

1/2022	Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack.
1/2022	Intracranial Hemorrhage in the TST Trial.
11/2021	Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack.
1/2021	Impact of Lower Versus Higher LDL Cholesterol Targets on Cardiovascular Events After Ischemic Stroke in Patients With Diabetes.
12/2020	Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin.
12/2020	Methodologies for pragmatic and efficient assessment of benefits and harms: Application to the SOCRATES trial.
11/2020	Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack in Prevention of Disabling Stroke: A Randomized Clinical Trial.
1/2020	Atorvastatin Reduces First and Subsequent Vascular Events Across Vascular Territories: The SPARCL Trial.
1/2020	Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA.
1/2020	A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pierre Amarenco Research Topics

Disease

131	Stroke (Strokes) 01/2022 - 01/2002
69	Ischemic Stroke 01/2022 - 01/2003
42	Transient Ischemic Attack 01/2022 - 09/2004
29	Hemorrhage 01/2022 - 07/2003
18	Coronary Disease (Coronary Heart Disease) 01/2020 - 01/2003
15	Atrial Fibrillation 01/2021 - 11/2007
14	Atherosclerosis 01/2022 - 04/2003
14	Embolic Stroke 08/2020 - 05/2009
14	Brain Infarction 01/2020 - 01/2002
13	Pathologic Constriction (Stenosis) 12/2020 - 04/2008
13	Myocardial Infarction 10/2019 - 01/2004
12	Cardiovascular Diseases (Cardiovascular Disease) 12/2018 - 12/2005
10	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022 - 12/2004
9	Embolism (Embolus) 01/2021 - 09/2009
9	Carotid Artery Diseases 01/2020 - 12/2004
8	Infarction (Infarctions) 12/2021 - 04/2005
8	Hemorrhagic Stroke 01/2020 - 01/2004
6	Cerebral Infarction 01/2020 - 01/2014
6	Dyslipidemias (Dyslipidemia) 01/2019 - 02/2011
6	Carotid Stenosis (Carotid Artery Stenosis) 01/2019 - 12/2008
6	Vascular Diseases (Vascular Disease) 01/2018 - 07/2003
5	Hypertension (High Blood Pressure) 01/2022 - 04/2003
5	Diabetes Mellitus 11/2019 - 09/2005
5	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2017 - 07/2003
4	Brain Ischemia (Cerebral Ischemia) 10/2019 - 10/2014
4	Type 2 Diabetes Mellitus (MODY) 01/2019 - 10/2011
4	Heart Failure 12/2018 - 06/2013
4	Cerebral Hemorrhage 02/2015 - 03/2013
4	Lacunar Stroke 01/2014 - 04/2005
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2020 - 08/2007
3	Atherosclerotic Plaque (Atheroma) 09/2019 - 01/2003
3	Thrombosis (Thrombus) 12/2018 - 01/2009
3	Ischemia 10/2014 - 01/2007
3	Coronary Artery Disease (Coronary Atherosclerosis) 07/2014 - 12/2005
3	Arterial Occlusive Diseases (Arterial Occlusive Disease) 06/2014 - 09/2009
3	Neoplasms (Cancer) 09/2005 - 01/2002
2	Inflammation (Inflammations) 12/2020 - 10/2014
2	Frailty 01/2020 - 01/2019
2	Peripheral Arterial Disease 12/2018 - 06/2013
2	Intracranial Embolism 06/2018 - 10/2014
2	Injection Site Reaction 01/2017 - 01/2017
2	Unstable Angina 01/2017 - 06/2013
2	Hypotension (Low Blood Pressure) 11/2016 - 06/2009

Drug/Important Bio-Agent (IBA)

41	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 07/2003
34	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2003
30	CholesterolIBA 01/2020 - 04/2003
24	LDL CholesterolIBA 01/2022 - 09/2005
22	LipidsIBA 01/2021 - 01/2003
19	TicagrelorIBA 01/2022 - 12/2015
19	oxidized low density lipoproteinIBA 01/2022 - 12/2004
19	Atorvastatin (Lipitor)FDA Link 01/2020 - 10/2006
16	RivaroxabanIBA 01/2021 - 01/2014
15	AnticoagulantsIBA 01/2022 - 09/2004
12	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2020 - 09/2004
12	Triglycerides (Triacylglycerol)IBA 01/2019 - 04/2009
10	HDL CholesterolIBA 01/2019 - 02/2008
10	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 08/2017 - 07/2003
8	HDL LipoproteinsIBA 12/2020 - 06/2009
8	Biomarkers (Surrogate Marker)IBA 12/2020 - 01/2007
8	Clopidogrel (Plavix)FDA Link 01/2020 - 09/2004
6	Lipoproteins (Lipoprotein)IBA 07/2020 - 06/2009
6	Vitamin K FDA Link 11/2019 - 01/2014
5	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 12/2020 - 11/2008
5	Factor Xa (Coagulation Factor Xa)IBA 11/2019 - 01/2014
5	terutrobanIBA 03/2019 - 11/2011
4	Neuroprotective AgentsIBA 12/2020 - 07/2010
4	Warfarin (Coumadin)FDA LinkGeneric 01/2020 - 01/2014
4	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2017 - 12/2004
4	Fibric Acids (Fibrates)IBA 06/2011 - 01/2004
3	Ezetimibe (Zetia)FDA Link 01/2022 - 01/2020
3	Matrix Metalloproteinases (MMPs)IBA 12/2020 - 04/2010
3	OsteopontinIBA 12/2020 - 09/2009
3	Factor Xa InhibitorsIBA 06/2018 - 01/2014
3	omega-Chloroacetophenone (Mace)IBA 01/2018 - 04/2016
3	bococizumabIBA 01/2017 - 08/2016
3	Trinitrotoluene (TNT)IBA 11/2016 - 04/2014
3	Glucose (Dextrose)FDA LinkGeneric 01/2015 - 04/2013
3	Blood Glucose (Blood Sugar)IBA 06/2014 - 06/2011
3	Niacin (Nicotinic Acid)FDA LinkGeneric 06/2011 - 06/2010
3	Antihypertensive Agents (Antihypertensives)IBA 05/2009 - 01/2003
2	Retinaldehyde (Retinal)IBA 12/2021 - 01/2016
2	CytokinesIBA 04/2021 - 07/2006
2	ResistinIBA 12/2020 - 12/2017
2	AdiponectinIBA 12/2020 - 12/2017
2	ChemokinesIBA 12/2020 - 04/2005
2	CD40 Ligand (CD40L)IBA 12/2020 - 12/2017
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2020 - 12/2017
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2020 - 04/2016
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2020 - 10/2006
2	PPAR alphaIBA 01/2019 - 12/2018
2	Insulin (Novolin)FDA Link 01/2019 - 01/2015
2	Peroxidase (Myeloperoxidase)IBA 12/2017 - 04/2003
2	Biological ProductsIBA 09/2016 - 06/2016

Therapy/Procedure

54	Therapeutics 01/2022 - 01/2003
17	Secondary Prevention 01/2022 - 01/2004
5	Thrombolytic Therapy 06/2015 - 09/2004
4	Thrombectomy 01/2020 - 09/2009
3	Carotid Endarterectomy 01/2017 - 03/2011
2	Contraindications 01/2020 - 01/2019
2	Aftercare (After-Treatment) 12/2018 - 05/2013